NASDAQ:IMPV - Imperva Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $55.52 0.00 (0.00 %) (As of 12/14/2018 05:08 AM ET)Previous Close$55.52Today's Range$55.51 - $55.5852-Week Range$39.58 - $57.65Volume1.69 million shsAverage Volume528,348 shsMarket Capitalization$1.95 billionP/E Ratio-198.29Dividend YieldN/ABeta1.29 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Imperva (NASDAQ:IMPV) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.14 Wall Street analysts have issued ratings and price targets for Imperva in the last 12 months. Their average twelve-month price target is $55.8958, suggesting that the stock has a possible upside of 0.68%. The high price target for IMPV is $70.00 and the low price target for IMPV is $48.00. There are currently 10 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: HoldHoldHoldHoldConsensus Rating Score: 2.292.292.252.40Ratings Breakdown: 0 Sell Rating(s)10 Hold Rating(s)4 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)10 Hold Rating(s)4 Buy Rating(s)0 Strong Buy Rating(s)2 Sell Rating(s)8 Hold Rating(s)6 Buy Rating(s)0 Strong Buy Rating(s)2 Sell Rating(s)5 Hold Rating(s)8 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $55.8958$55.8958$54.0909$53.00Price Target Upside: 0.68% upside0.35% upside4.60% downside3.21% upsideImperva (NASDAQ:IMPV) Consensus Price Target History Imperva (NASDAQ:IMPV) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails11/6/2018Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$56.00Low10/11/2018JPMorgan Chase & Co.UpgradeUnderweight ➝ NeutralLow10/11/2018DA DavidsonSet Price TargetHold$46.00 ➝ $56.00Low10/11/2018Evercore ISIReiterated RatingOutperform ➝ Hold$55.75Low10/11/2018MacquarieDowngradeOutperform ➝ Neutral$55.00Low10/11/2018Morgan StanleyUpgradeUnderweight ➝ Equal Weight$56.00Low7/27/2018Stifel NicolausLower Price TargetHold ➝ Buy$50.00 ➝ $48.00High7/27/2018Monness Crespi & HardtDowngradeBuy ➝ Neutral$52.00High7/27/2018OppenheimerDowngradeOutperform ➝ Market Perform$70.00High7/27/2018UBS GroupDowngradeOutperform ➝ Market PerformHigh6/14/2018StephensBoost Price TargetOverweight$61.00 ➝ $67.00High4/29/2018BTIG ResearchReiterated RatingHoldMedium2/9/2018Imperial CapitalBoost Price TargetOutperform ➝ Outperform$50.00 ➝ $55.00Low2/9/2018Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$52.00High10/24/2017KeyCorpReiterated RatingHoldN/A10/10/2017William BlairDowngradeOutperform ➝ Market PerformN/A10/9/2017Wells Fargo & CoDowngradeOutperform ➝ Market PerformN/A6/7/2017Susquehanna BancsharesInitiated CoveragePositive ➝ Positive$60.00Low(Data available from 12/14/2016 forward) This page was last updated on 12/14/2018 by MarketBeat.com StaffFeatured Article: Why is the conference call important?